Synopsys, Inc. (NASDAQ:SNPS) Shares Sold by Glenmede Trust Co. NA

Glenmede Trust Co. NA decreased its position in Synopsys, Inc. (NASDAQ:SNPS) by 12.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,322 shares of the semiconductor company’s stock after selling 5,994 shares during the quarter. Glenmede Trust Co. NA’s holdings in Synopsys were worth $20,419,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ORG Partners LLC boosted its stake in shares of Synopsys by 600.0% during the 2nd quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 36 shares during the last quarter. Pacifica Partners Inc. bought a new position in shares of Synopsys during the third quarter worth about $25,000. Tsfg LLC grew its stake in Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares in the last quarter. Chris Bulman Inc acquired a new stake in Synopsys during the second quarter valued at approximately $30,000. Finally, Hazlett Burt & Watson Inc. lifted its holdings in Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Trading Down 1.1 %

Shares of NASDAQ:SNPS opened at $547.74 on Thursday. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38. The firm has a market cap of $84.14 billion, a P/E ratio of 56.82, a P/E/G ratio of 3.43 and a beta of 1.08. The company has a 50 day moving average of $524.12 and a 200-day moving average of $545.71.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SNPS. Piper Sandler reduced their price target on shares of Synopsys from $687.00 to $670.00 and set an “overweight” rating on the stock in a research report on Thursday, October 24th. JPMorgan Chase & Co. raised their target price on shares of Synopsys from $655.00 to $685.00 and gave the stock an “overweight” rating in a report on Thursday, August 22nd. Loop Capital assumed coverage on Synopsys in a research report on Monday, November 11th. They set a “buy” rating and a $675.00 price target on the stock. Robert W. Baird raised their price target on Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a report on Thursday, August 22nd. Finally, Needham & Company LLC restated a “buy” rating and set a $640.00 price objective on shares of Synopsys in a research note on Tuesday, October 22nd. One investment analyst has rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $653.80.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.